353 related articles for article (PubMed ID: 30015053)
1. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
2. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
Kak M; Nanda R; Ramsdale EE; Lukas RV
J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
[TBL] [Abstract][Full Text] [Related]
3. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy.
Niwińska A; Rudnicka H; Murawska M
Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal metastasis from systemic cancer: Review and update on management.
Wang N; Bertalan MS; Brastianos PK
Cancer; 2018 Jan; 124(1):21-35. PubMed ID: 29165794
[TBL] [Abstract][Full Text] [Related]
6. Management of leptomeningeal metastases: Prognostic factors and associated outcomes.
Brower JV; Saha S; Rosenberg SA; Hullett CR; Ian Robins H
J Clin Neurosci; 2016 May; 27():130-7. PubMed ID: 26778048
[TBL] [Abstract][Full Text] [Related]
7. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
Lee YC; Hsieh CC; Chuang JP; Li CY
Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.
Jo JC; Kang MJ; Kim JE; Ahn JH; Jung KH; Gong G; Kim HH; Ahn SD; Kim SS; Son BH; Ahn SH; Kim SB
Cancer Chemother Pharmacol; 2013 Jul; 72(1):201-7. PubMed ID: 23670641
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal Metastasis in a Breast Cancer Treated with Two Lines of Intrathecal Chemotherapy - a Case Report.
Mikudova V; Rejlekova K; Gyarfas J; Oravcova I; Chovanec M; Mardiak J; Mego M
Klin Onkol; 2019; 32(2):139-142. PubMed ID: 30995855
[TBL] [Abstract][Full Text] [Related]
11. Leptomeningeal disease.
Groves MD
Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
[TBL] [Abstract][Full Text] [Related]
12. Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM).
Niwińska A; Pogoda K; Michalski W; Kunkiel M; Jagiełło-Gruszfeld A
J Neurooncol; 2018 May; 138(1):191-198. PubMed ID: 29435818
[TBL] [Abstract][Full Text] [Related]
13. [Three Cases of Intrathecal Chemotherapy with Ventricular Catheter for the Treatment of Leptomeningeal Metastasis from Breast Cancer].
Miyoshi K; Takahashi H; Uno M; Akai M; Moriyama E; Nakagawa T; Nomura T
Gan To Kagaku Ryoho; 2018 Dec; 45(12):1767-1769. PubMed ID: 30587738
[TBL] [Abstract][Full Text] [Related]
14. High-dose intravenous methotrexate in the management of breast cancer with leptomeningeal disease: Case series and review of the literature.
Kapke JT; Schneidewend RJ; Jawa ZA; Huang CC; Connelly JM; Chitambar CR
Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):189-193. PubMed ID: 31629723
[TBL] [Abstract][Full Text] [Related]
15. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
16. Complete response of leptomeningeal carcinomatosis secondary to breast cancer.
Troussier I; Canova C; Klausner G
Breast; 2020 Dec; 54():328-330. PubMed ID: 33278649
[TBL] [Abstract][Full Text] [Related]
17. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC
Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.
Le Rhun E; Wallet J; Mailliez A; Le Deley MC; Rodrigues I; Boulanger T; Lorgis V; Barrière J; Robin YM; Weller M; Bonneterre J
Neuro Oncol; 2020 Apr; 22(4):524-538. PubMed ID: 31637444
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist].
Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T
Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal metastasis in breast cancer - a systematic review.
Scott BJ; Oberheim-Bush NA; Kesari S
Oncotarget; 2016 Jan; 7(4):3740-7. PubMed ID: 26543235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
